NCT03224312

Chongqing Primary Aldosteronism Study

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 1,500 (estimated)
• Sponsor: Chongqing Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

We intends to conduct a series of original clinical research about PA, and establish a large cohort of PA and essential hypertension patients with long-term follow-up of cardiovascular events, renal end points etc. We will establish a large sample of blood, urine, adrenal tissue of the subjects, and the genomics,metabonomics, proteomics database, to explore the mechanism of the PA and target organ damage, risk factors, diagnostic methods and biomarkers.

Detailed description

This study will include the subjects of a series of studies on hypertension conducted by our team, including essential hypertension, PA subjects, and establish a large sample database and specimen bank through follow-up and omics analysis.

Conditions

• Primary Aldosteronism

Interventions

Type	Name	Description
OTHER	no intervention	no intervention

Timeline

• Start date: 2016-10-01
• Primary completion: 2027-12-31
• Completion: 2028-12-31
• First posted: 2017-07-21
• Last updated: 2023-09-06

Locations

1 site across 1 country: China